Ditchcarbon
  • Customers
  1. Organizations
  2. Insulet
Public Profile
Medical Device Manufacturing
US
updated 9 days ago

Insulet

Company website

Insulet Corporation, commonly known for its innovative Omnipod® Insulin Management System, is a leading player in the diabetes care industry. Headquartered in the United States, Insulet operates primarily in North America and Europe, focusing on developing advanced insulin delivery solutions. Founded in 2000, the company has achieved significant milestones, including the launch of its tubeless insulin pump, which revolutionised diabetes management for many patients. Insulet's core product, the Omnipod, stands out due to its unique design that offers a wireless, waterproof, and discreet insulin delivery system. This innovative approach has positioned Insulet as a market leader, recognised for enhancing the quality of life for individuals with diabetes. With a commitment to continuous improvement and patient-centric solutions, Insulet remains at the forefront of diabetes technology, driving advancements that empower users to manage their condition effectively.

DitchCarbon Score

How does Insulet's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

39

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

26

Industry Benchmark

Insulet's score of 39 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.

66%

Let us know if this data was useful to you

Insulet's reported carbon emissions

In 2024, Insulet Corporation reported total greenhouse gas emissions of approximately 13,830,000 kg CO2e, comprising 1,383,000 kg CO2e from Scope 1 and 11,467,000 kg CO2e from Scope 2 emissions. This marks a notable increase in emissions compared to 2023, where the company recorded about 1,316,000 kg CO2e in Scope 1 and 3,977,000 kg CO2e in Scope 2, totalling approximately 5,293,000 kg CO2e. Insulet has made significant strides in reducing its carbon footprint, achieving a reduction of about 19% in Scope 1 emissions from 2020 to 2021. The company is committed to a net-zero transition, with plans to establish targets for greenhouse gas emissions reduction and increase the use of renewable energy in its operations by 2030. This commitment extends to both Scope 1 and Scope 2 emissions, with ongoing investments in renewable energy and sustainable practices, including the development of a new manufacturing facility in Malaysia aimed at achieving Green Building Index (GBI) and Leadership in Energy and Environmental Design (LEED) Silver certifications. Insulet's climate strategy is focused on long-term sustainability, with a blueprint for achieving net-zero emissions by 2050. The company is actively working towards these goals, although specific numerical targets for emissions reductions in the near term have not been disclosed. Overall, Insulet's efforts reflect a proactive approach to addressing climate change and minimising its environmental impact.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20202021202220232024
Scope 1
1,709,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 2
3,761,000
0,000,000
0,000,000
0,000,000
00,000,000
Scope 3
-
-
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Insulet's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Insulet is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Insulet is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

MicroTech Medical (Hangzhou) Co., Ltd.

CN
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 4 days ago

Ypsomed

CH
•
Medical, precision and optical instruments, watches and clocks (33)
Updated about 21 hours ago

Zealand Pharma A/S

DK
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

embecta

US
•
Food waste for treatment: incineration
Updated 14 days ago

Roche Diabetes Care, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Medtronic MiniMed, Inc.

US
•
Health and social work services (85)
Updated 14 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.10
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy